New York, Feb 7, 2026, 15:18 EST — That’s it for today’s session; markets have closed.
Philip Morris International finished the day up 0.45% at $182.81. The stock picked up after the company lifted its 2026 profit outlook, pointing to momentum in its nicotine pouch business.
The situation is reaching a breaking point, with the stock turning into a barometer for whether smoke-free products can actually deliver profits in a market packed with competitors. Zyn sits at the center of the storm. Traders have their eyes glued to any hint that surging volumes aren’t eating into pricing strength.
With U.S. markets shut over the weekend, all eyes shift to what Monday brings. Profit forecasts have sharpened, yet there’s fresh anxiety: will competitors ramp up discounting? If so, margins could take a hit—fast.
Philip Morris International notched adjusted fourth-quarter earnings of $1.70 a share, up from $1.55 the previous year, with net revenues jumping 6.8% to $10.362 billion. The tobacco giant is projecting first-quarter adjusted EPS in the $1.80 to $1.85 range and has set its sights on 2026 reported diluted EPS between $7.87 and $8.02. Management also reaffirmed longer-term growth targets, emphasizing “organic” gains—those stripped of currency swings and deal impacts. Philip Morris International
Philip Morris chief Jacek Olczak told Reuters the company has revamped Zyn products in the pipeline, but any rollout depends on regulatory clearance as rivals turn up the heat. Jefferies analyst Andrei Andon-Ionita called Philip Morris’s fresh targets a “reassuring outlook” for growth, flagging British American Tobacco as a major U.S. nicotine pouch competitor. Reuters
Stocks barely flinched ahead of the weekend, while U.S. indexes shot higher on Friday. The Dow punched past 50,000 at the close, marking a record. PMI, by contrast, barely moved—some traders chalk that up to defensive cash staying out rather than chasing the rally.
Desks go into early next week scanning for analyst updates and any hints about pouch market share talk. Options tend to wake up in this sort of environment; when consumer names shift on category data rather than headline spikes, flows sometimes get lively.
Even so, there’s an obvious risk here. If a price war breaks out in the pouch aisle, volume might climb, but revenue and profit per can could shrink. That’s a setup where forecasts slip, despite the company winning more shelf space.
Heated tobacco products like IQOS remain under the microscope; a quick change in taxes or pricing can swing demand sharply. Should the main markets lose momentum, the stock’s case for smoke-free growth could face real pressure.
Income-seeking investors are circling PMI’s next dividend schedule: the company announces on March 5, 2026, shares trade ex-dividend March 19, and checks are due to arrive April 13.
